Moneycontrol
Sep 14, 2017 03:06 PM IST | Source: Moneycontrol.com

Omkar Pharma: Outcome of board meeting

Dear Sir,

Pursuant to the provisions of Regulation 30 the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015, please note that the Board in its meeting held on 14th September, 2017 has Considered and approved the Unaudited Financial Results for the quarter ended 30th June, 2017 along with Limited Review Report.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More
Dear Sir,

Pursuant to the provisions of Regulation 30 the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015, please note that the Board in its meeting held on 14th September, 2017 has Considered and approved the following items:



1) Unaudited Financial Results for the quarter ended 30th June, 2017 along with Limited Review Report.
Source : BSE
Sections
Follow us on
Available On